Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000930413-19-002491
Filing Date
2019-09-16
Accepted
2019-09-16 16:16:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 c94263_sch13g.htm SC 13G 94081
  Complete submission text file 0000930413-19-002491.txt   95872
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Subject) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-33655 | Film No.: 191094899
SIC: 2834 Pharmaceutical Preparations

Mailing Address 165 MASON STREET, 3RD FLOOR GREENWICH CT 06830
Business Address 165 MASON STREET, 3RD FLOOR GREENWICH CT 06830 203 971-3300
GREAT POINT PARTNERS LLC (Filed by) CIK: 0001281446 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G